Thompson, D S <br/><br/>
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 1995 
 - 499-507 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/0009-9236(95)90034-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Chromatography, High Pressure Liquid<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Etoposide--administration & dosage<br/>Female<br/>Half-Life<br/>Humans<br/>Infusions, Intravenous<br/>Leukopenia--chemically induced<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Organophosphorus Compounds--administration & dosage